Diagnostic accuracy of hepatocellular carcinoma risk prediction models during antiviral therapy in chronic hepatitis B patients
Author:
Affiliation:
1. Department of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan
2. NAFLD Research Center Department of Medicine University of California San Diego La Jolla California USA
Funder
Uehara Memorial Foundation
Japan Agency for Medical Research and Development
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13684
Reference6 articles.
1. Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B;Chon HY;Hepatol Res,2021
2. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers;Wong VW;J Clin Oncol,2010
3. Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment;Kirino S;J Viral Hepat,2021
4. Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinoma;Suzuki Y;Hepatol Res,2019
5. Clinical utility of mac‐2 binding protein glycosylation isomer in chronic liver diseases;Tamaki N;Ann Lab Med,2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3